如何治疗CAR T细胞治疗相关神经毒性的独特且难以处理的病例
随着嵌合抗原受体(CAR)T细胞治疗适应证扩大,毒性谱不断演变,现有指南主要针对细胞因子释放综合征和免疫效应细胞相关神经毒性综合征(ICANS),对合并神经基础疾病患者及罕见神经毒性表现缺乏指导。本文呈现3例接受CAR T细胞治疗后出现独特类型神经毒性的患者场景,并基于经验描述评估与管理方法,旨在提高对新兴和异常并发症的认识,帮助机构建立处理框架。
要点
- 本文报告3例CAR T细胞治疗后出现独特类型神经毒性的患者场景。
- 罕见神经毒性包括CAR T细胞治疗相关脑水肿、严重运动并发症或迟发性神经毒性。
- 由于客观数据有限,评估与管理方法基于经验描述。
核心结论
- 本文旨在提高对新兴和异常并发症的认识,讨论治疗方法,帮助机构和医疗保健提供者建立框架以最佳处理异常神经毒性,最终改善患者结局。
研究设计与样本
- 本文呈现3例接受CAR T细胞治疗后出现独特类型神经毒性的患者场景,并基于经验描述评估与管理方法,因客观数据有限。
主要发现
- 本文呈现3例接受CAR T细胞治疗并出现独特类型神经毒性的患者场景。
- 罕见神经毒性表现包括CAR T细胞治疗相关脑水肿、严重运动并发症或迟发性神经毒性。
- 现有ICANS管理指南对合并神经基础疾病患者及罕见神经毒性表现的处理指导有限。
临床怎么用
- 本文基于经验描述对独特类型神经毒性患者的评估与管理方法,因客观数据有限。
局限性
- 原文述及客观数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With growing indications for chimeric antigen receptor (CAR) T-cell therapy, toxicity profiles are evolving. There is an urgent and unmet need of approaches to optimally manage emerging adverse events that extend beyond the standard paradigm of cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome (ICANS). Although management guidelines exist for ICANS, there is little guidance on how to approach patients with neurologic comorbidities, and how to manage rare neurotoxicity presentations, such as CAR T-cell therapy-related cerebral edema, severe motor complications or late-onset neurotoxicity. In this study, we present 3 scenarios of patients treated with CAR T cells who develop unique types of neurotoxicity, and we describe an approach for the evaluation and management based on experience because objective data are limited. The goal of this study is to develop an awareness of emerging and unusual complications, discuss treatment approaches, and help institutions and health care providers establish frameworks to navigate how to best address unusual neurotoxicities to ultimately improve patient outcomes.
引用
- Santomasso BD, Gust J, Perna F, et al. How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity. Blood. 2023. PMID: 36877916. doi:10.1182/blood.2022017604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。